Bioceres price target lowered to $18 from $22.50 at Canaccord

Canaccord lowered the firm’s price target on Bioceres to $18 from $22.50 and keeps a Buy rating on the shares. The firm said normalization of weather and planting activity should allow resumption of growth for the company, compounded by potential catch-up demand from farmers who have delayed purchases until the conclusion of Argentinian elections.